A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study (Q43284690)
Jump to navigation
Jump to search
scientific article published on 26 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study |
scientific article published on 26 August 2009 |
Statements
1 reference
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study (English)
1 reference
Carol Aghajanian
1 reference
John A Blessing
1 reference
Kathleen M Darcy
1 reference
Gary Reid
1 reference
Koen DeGeest
1 reference
Stephen C Rubin
1 reference
Robert S Mannel
1 reference
Jacob Rotmensch
1 reference
Russell J Schilder
1 reference
William Riordan
1 reference
Gynecologic Oncology Group
1 reference
26 August 2009
1 reference
1 reference
115
1 reference
2
1 reference
215-220
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference